We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Campylobacter Rely on Pseudomonas to Infect Humans

By LabMedica International staff writers
Posted on 27 Oct 2010
The interaction between the different species of bacteria seems to be a mechanism for Campylobacter jejuni to remain viable and survive ambient oxygen levels. More...


C. jejuni is a microaerophilic gram-negative bacillus that causes febrile diarrhea or dysentery; vomiting or bloody stool are often noted with severe abdominal pain. The disease is most common among children and lasts one to four days.

Although Campylobacter infections are rarely life threatening, they are extremely debilitating and they have been linked with the development of Guillain-Barré syndrome, one of the leading causes of nontrauma-induced paralysis worldwide. The bacteria do not grow well at room temperature or in an oxygen-rich environment as it well adapted to life in the intestines of animals and humans. However, it is normally transmitted from contaminated chicken meat, as it is frequently found in the intestines of chickens, where it apparently does not result in any symptoms.

Scientists at the University of Veterinary Medicine (Vienna, Austria), have recently discovered that interactions with other bacteria allow C. jejuni to survive under hostile, oxygen-rich conditions. Campylobacter survived atmospheric oxygen levels for no longer than 18 hours when incubated alone or together with bacteria such as Proteus mirabilis, Citrobacter freundii, Micrococcus luteus or Enterococcus faecalis. However, when incubated together with various strains of Pseudomonas, Campylobacter were found to survive for much longer, in some cases over 48 hours, which would be easily long enough to cause infection. An in vitro assay was used to test the bacteria's survival rate.

There were differences in the extent of prolonged survival depending on the sources of the Campylobacter analyzed, but all isolates of all strains clearly survived significantly longer in the presence of Pseudomonas bacteria than when cultured alone. And the Campylobacter cells did not change shape when cultured together with Pseudomonas under oxygen-rich conditions, unlike when they were cultured alone, providing further indications of an interaction between the species. Interestingly, there is no evidence that the Pseudomonas benefit at all from the interaction, although they effectively facilitate the survival of Campylobacter under adverse conditions.

This microbial commensalism was diverse in C. jejuni isolates from different sources: isolates from chicken meat and humans in coculture with Ps. putida were able to use this survival support better than fecal isolates from broilers. Scanning electron microscopy revealed the development of fiber-like structures braiding Ps. putida and C. jejuni cells. Hence, it seems that microaerophilic C. jejuni is able to survive ambient atmospheric oxygen tension by metabolic commensalism with Pseudomonas species. This bacterial-bacterial interaction might set the basis for the survival of C. jejuni on chicken meat and thus be the prerequisite step in the pathway towards human infection. The study was published the October 2010 issue of Applied and Environmental Microbiology.

Related Links:
University of Veterinary Medicine




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Automatic CLIA Analyzer
Shine i6000
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: LVOne uses blood-based biomarkers to detect stroke and identify large vessel occlusion before hospital arrival, providing objective results earlier than traditional assessments. (Photo courtesy of UpFront Diagnostics)

First-of-Its-Kind Rapid Blood Test Gains CE Mark to Support Prehospital Stroke Triage

Rapid stroke identification before hospital arrival is critical because treatment efficacy declines with every minute of delay. However, definitive assessment typically requires hospital-based imaging,... Read more

Molecular Diagnostics

view channel
Image: MPNST is a cancer of the connective tissue surrounding peripheral nerves, with NF1 being a key risk factor (Image Credit: Nephron/Wikimedia Commons (CC BY-SA 3.0)

Liquid Biopsy Shows Promise for Detecting and Monitoring Malignant Nerve Sheath Tumors

Malignant peripheral nerve sheath tumor (MPNST) is one of the most serious cancers affecting people with neurofibromatosis type 1 (NF1), yet timely recognition remains difficult. Clinicians often struggle... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.